ArticleProstate cancer and prostatic diseases2026

Cytoplasmic versus nuclear localization of androgen receptor splice variant 7 as a predictor of benefit from androgen receptor pathway inhibitors in metastatic castration-resistant prostate cancer (PROPHECY trial).

Santosh Gupta et al.PubMed ↗Publisher ↗

No numbers read from the abstract.